Research.Patient.info
relapsing multiple sclerosis (RMS) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes (PRO) in patients with relapsing multiple sclerosis (RMS) transitioning from fumarate-based RMS approved therapies or fingolimod.
This study looks at how well a medicine called Kesimpta works for people with a type of multiple sclerosis called relapsing multiple sclerosis (RMS). It also checks for side effects and how people feel on the treatment, especially those switching from other MS medicines.
Poland · Bulgaria · Portugal - ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-Label, Rater-Blind, Randomized, Multi-Center, Parallel-Arm, Active-Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC monthly vs. First Line DMT - physician’s choice in the treatment of newly diagnosed RMS (STHENOS)
This study is testing a new way to treat multiple sclerosis (MS) called ofatumumab. It compares this new treatment to standard MS medications in people recently diagnosed with a specific type of MS called relapsing multiple sclerosis (RMS). The aim is to see which treatment works best to prevent MS attacks and stop the disease from getting worse.
France · Germany · Italy